Mar 23, 2016 ... Plaintiff Victoria Cerveny allegedly took Clomid in September and October 1992. Shortly ... The case name is Cerveny et al v. Sanofi et al.
Parties, docket activity and news coverage of federal case Amgen Inc. et al v. Sanofi et al, case number 1:14-cv-01317, from Delaware Court.
Oct 17, 2014 ... Amgen Inc. v. Sanofi et al. Plaintiff: Amgen Inc. Defendant: Sanofi, Aventisub LLC and Regeneron Pharmaceuticals Inc. Case Number: 1: ...
Mar 22, 2016 ... Very recently, Zhang et al. introduced a different approach to reduce the ... In 2014, Sanofi-Genzyme published a combinatorial approach of beta-1 .... Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. ... Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, et al.
sanofi ; Laurence Hatteville sanofi , Samira Ziti-Ljajic sanofi , Anne Caron sanofi ( C) ..... Francisco JA, Cerveny CG, Meyer DL, Mixan BJ, Klussman K, Chace DF, et al. ... Coiffier B, Ribrag V, Dupuis J, Tilly H, Haioun C, Morschhauser F, et al.
Mar 3, 2017 ... breast cancer (18), and the discontinuation of Sanofi's SAR3419 in diffuse large ...... Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, et al. ... de Guibert S, Dupuis J, Ribrag V, Bouabdallah R, et al.
Behrens and Liu (2014) and Panowksi et al. ... Sanofi-Genzyme, Glycoengineering .... The importance of conjugation site was also described by Strop et al.
Dec 4, 2010 ... The response rates and time to progression were similar (49% vs 43% and 7 months vs 10 months in arm A .... Calistoga, Johnson & Johnson, EMD Serono, sanofi-aventis, Millenium, Biotest, Cephalon, Pharmion, Eisai, ... Hagenbeek A,; Fayad L,; Delwail V,; et al. .... Baum PR,; Cerveny C,; Gordon B,; et al.
V Diehl, J Franklin, M Pfreundschuh , etal: Standard and increased-dose BEACOPP ... CG Cerveny, DL Meyer , etal: cAC10-vcMMAE, an anti-CD30- monomethyl ...